glp-1 drugs in development History of glucagon-like peptide-1 receptor agonists GLP-1 Genetics: How Genes Affect
Description
CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries
Just as every human body starts with one cell, every healthcare advancement begins with basic science
The trial validates an oral maintenance strategy following successful injectable-led weight loss, promises to improve patient convenience and adherence through a simple daily pill, and does so with a reassuring safety profile
Friedreich ataxia: Recent evidence shows that exenatide, a GLP-1 receptor agonist, induces frataxin expression and improves mitochondrial function in models of Friedreich ataxia, suggesting a potential therapeutic avenue for mitochondrial dysfunction in neurodegenerative diseases [46]
doi: 10.2337/db14-0302 37 BurmeisterMAAyalaJDruckerDJAyalaJE
